C. Debieuvre

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Paolo Barone, Werner Poewe, Stefan Albrecht et al. · The Lancet Neurology · 2010 · 560 citations

Medicine, Pharmacology, Pharmacotherapy +14

Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release

Robert A. Hauser, Mark Forrest Gordon, Yoshikuni Mizuno et al. · Parkinson s Disease · 2014 · 78 citations · Full text

Medicine, Neuroscience, Pharmacotherapy +17

Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease

Olivier Rascol, Paolo Barone, Robert A. Hauser et al. · Movement Disorders · 2010 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced <scp>P</scp>arkinson's disease

Robert A. Hauser, Anthony H.V. Schapira, Paolo Barone et al. · European Journal of Neurology · 2014 · 33 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease

Anthony H.V. Schapira, Paolo Barone, Robert A. Hauser et al. · European Journal of Neurology · 2012 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +16